跳至主要内容
临床试验/CTRI/2019/08/020659
CTRI/2019/08/020659尚未招募1 期

An open label Single arm Clinical study to evaluate the efficacy of Dadimadi ghrita orally in Sukhaprasava

Self0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
发起方
Self

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Primi Gravida with 36 weeks of gestation
  • Preganant women aged between 18 to 35 yrs
  • Single life intrauterine gestation with cephalic presentation
  • Subject who agree to participate and is ready to sign the infrom cosent from

排除标准

  • MULTI GRAVIDA WOMEN ABSOLUTE INDICATION OF CAESAREAN SECTION SUCH AS CENTRAL PLACENTA PREVIA CONTRACTED PELVIS OR CEPHELO PELVIC DISPROPORTION
  • PELVIC MASS ADVANCE CARCINOMA OF CERVIX VAGINAL HIGH RISK PREGNANCY MEDICAL ILLNESS PREEXISTING OR ASSOCIATE WITH PREGNANCY LIKE GESTATIONAL DIABETICS MELLITUS THYROID DISORDERS ASTHAMA PREECLAMSIA WOMEN WITH OTHER MEDICAL SURGICAL ILLNESS LIKE PULMONARY DISEASE PSYCHIATRIC ILLNESS CARDIAC DISEASE MALARIA AND HIV HBSAG
  • ANTEPARTUM HAEMORRHAGE HYDRAMNIOS

研究者

发起方
Self

相似试验